Jean Viggers

416 total citations
8 papers, 339 citations indexed

About

Jean Viggers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Jean Viggers has authored 8 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Jean Viggers's work include Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Jean Viggers is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Neuroscience and Neuropharmacology Research (2 papers). Jean Viggers collaborates with scholars based in United Kingdom, United States and Netherlands. Jean Viggers's co-authors include Sharon C. Cheetham, David J. Heal, M.R. Prow, W. R. Buckett, Nigel K.H. Slater, Phil Jeffrey, Kevin D. Read, Adam Lucas, Jeanette Watson and Rod A. Porter and has published in prestigious journals such as European Journal of Pharmacology, Neuropharmacology and Drug Metabolism and Disposition.

In The Last Decade

Jean Viggers

8 papers receiving 311 citations

Peers

Countries citing papers authored by Jean Viggers

Since Specialization

Citations

This map shows the geographic impact of Jean Viggers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Viggers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Viggers more than expected).

Fields of papers citing papers by Jean Viggers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Viggers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Viggers. The network helps show where Jean Viggers may publish in the future.

Co-authorship network of co-authors of Jean Viggers

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Viggers. A scholar is included among the top collaborators of Jean Viggers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Viggers. Jean Viggers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity 2010 ·Bioorganic & Medicinal Chemistry Letters ·Mark Hadden, (unknown), Alan J. Henderson, M. D. Surman, (unknown), Yuri L. Khmelnitsky, Steven P. Vickers, Jean Viggers, Sharon C. Cheetham, Peter R. Guzzo	11
2	5-(Pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl)indazoles as MCH-1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·M. D. Surman, Emily Freeman, (unknown), Mark Hadden, Alan J. Henderson, Guowei Jiang, (unknown), (unknown), Yuri L. Khmelnitsky, Steven P. Vickers, Jean Viggers, Sharon C. Cheetham, Peter R. Guzzo	14
3	Tetrahydrocarboline analogs as MCH-1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Alan J. Henderson, (unknown), (unknown), Mark Hadden, (unknown), Yuri L. Khmelnitsky, (unknown), M. D. Surman, Sharon C. Cheetham, Steven P. Vickers, Jean Viggers, Peter R. Guzzo	10
4	Receptor Occupancy and Brain Free Fraction 2009 ·Drug Metabolism and Disposition ·Jeanette Watson, (unknown), Adam Lucas, (unknown), Jean Viggers, Sharon C. Cheetham, Phil Jeffrey, Rod A. Porter, Kevin D. Read	80
5	Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine 2000 ·Neuropharmacology ·Sharon C. Cheetham, Jean Viggers, (unknown), David J. Heal	6
6	[3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments 1996 ·Neuropharmacology ·Sharon C. Cheetham, Jean Viggers, (unknown), M.R. Prow, David J. Heal	108
7	[3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments 1993 ·Neuropharmacology ·Sharon C. Cheetham, Jean Viggers, Nigel K.H. Slater, David J. Heal, W. R. Buckett	109
8	The inhibition constants for blockade of [3H]5-hydroxytryptamine reuptake are variable and dependent on a tissue concentration 1990 ·European Journal of Pharmacology ·Sharon C. Cheetham, Jean Viggers, (unknown), D.J. Heal, W. R. Buckett	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact